We read with great interest the article by Rong et al. (1) on the associations of hemochromatosis gene (HFE) polymorphisms (C282Y and H63D) with type 2 diabetes mellitus. The authors stated, "… persons with a D allele may have a moderately increased risk of type 2 diabetes mellitus" (1, p. 461) (additive model (D allele vs. H allele): odds ratio (OR) = 1.20, 95% confidence interval (CI): 1.03, 1.41, P = 0.02; dominant model (DD + HD vs. HH genotype): OR = 1.12, 95% CI: 1.00, 1.25, P = 0.04). This is a very important investigation because there were conflicting results with regard to these associations in the original studies. However, we would like to draw attention to the following aspects of the article.
First, the data presented by Rong et al. (1) were not in accord with those provided by the original publications. . When we reanalyzed the data, the association was no longer significant in an additive model (OR = 1.16, 95% CI: 0.99, 1.36; P = 0.07; I 2 = 59.9%) ( Figure 1 ). The association was still not significant after sensitivity analysis excluding 1 study (4) exerting substantial impact on between-study heterogeneity in an additive model (OR = 1.10, 95% CI: 0.99, 1.21; P = 0.12; I 2 = 26.5%), although a marginally significant association was found in the dominant model (OR = 1.17, 95% CI: 1.01, 1.35; P = 0.05; I 2 = 39.1%).
Second, considering the inconsistency among different genetic models, Salanti et al. (5) proposed a method for the choice of genetic models based on the ratio of logscale effect (λ = log(OR HD/HH )/log(OR DD/HH )), and they suggested that an additive model of inheritance is most plausible for type 2 diabetes mellitus when the inheritance mode is unknown for gene-disease association studies. When using the random-effects logistic regression models treating the multiple genotypes (HH, HD, and DD) as independent variables as proposed by Salanti et al. (5) and Bagos and Nikolopoulos (6), we found that the association was still not significant (log(OR HD/HH ) = 0.10, 95% CI: −0.03, 0.22, P = 0.12; log(OR DD/HH ) = 0.31, 95% CI: −0.15, 0.77, P = 0.18). When the choice of genetic models was taken into consideration, the results also suggested an additive model (λ = log(OR HD/HH )/log(OR DD/HH ) = 0.32) instead of a dominant model (λ = 1 indicates a dominant model).
Third, according to the hierarchy for grading the credibility of molecular evidence in complex diseases (7), the effect observed in the study by Rong et al. should be small or very small instead of moderate (very small: OR = 1-1.2; small: OR = >1.2-2; moderate: OR = >2-5; large: OR = >5). All statistical analyses were performed with Stata, version 10.1, software (StataCorp LP, College Station, Texas). All reported probabilities (P values) were 2 sided, with P ≤ 0.05 considered significant. In our opinion, readers will have a better understanding of the results by Rong et al. (1) if they take into account the above-mentioned data analysis.
